Aclaris Therapeutics Shares Outstanding 2014-2018 | ACRS

Aclaris Therapeutics shares outstanding history from 2014 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Aclaris Therapeutics shares outstanding for the quarter ending June 30, 2018 were 0.031B, a 16.36% increase year-over-year.
  • Aclaris Therapeutics 2017 shares outstanding were 0.028B, a 31.22% increase from 2016.
  • Aclaris Therapeutics 2016 shares outstanding were 0.021B, a 250.68% increase from 2015.
  • Aclaris Therapeutics 2015 shares outstanding were 0.006B, a 255.06% increase from 2014.
Aclaris Therapeutics Annual Shares Outstanding
(Millions of Shares)
2017 28
2016 21
2015 6
2014 2
2013 1
Aclaris Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
Q2 2018 31
Q1 2018 31
Q4 2017 28
Q3 2017 29
Q2 2017 27
Q1 2017 26
Q4 2016 21
Q3 2016 21
Q2 2016 21
Q1 2016 20
Q4 2015 6
Q3 2015 2
Q2 2015 2
Q1 2015 2
Q4 2014 0
Q3 2014 2
Q4 2013 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.415B $0.002B
Aclaris Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing drugs to met needs in dermatology. Its drug candidate consists of A-101, a high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis a common non-malignant skin tumor and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts which are in different clinical trial. Aclaris Therapeutics, Inc. is headquartered in Malvern, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $52.332B 11.09
Zoetis (ZTS) United States $43.403B 31.50
Tilray (TLRY) United States $15.428B 0.00
Grifols (GRFS) Spain $13.247B 16.17
Neurocrine Biosciences (NBIX) United States $9.956B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $9.380B 13.80
Nektar Therapeutics (NKTR) United States $8.465B 9.90
Ionis Pharmaceuticals (IONS) United States $6.195B 0.00
Catalent (CTLT) United States $6.036B 25.98
Sage Therapeutics (SAGE) United States $5.611B 0.00
Impax Laboratories (AMRX) United States $5.590B 29.73
United Therapeutics (UTHR) United States $5.377B 6.90
Loxo Oncology (LOXO) United States $4.834B 0.00
FibroGen (FGEN) United States $4.189B 0.00
Endo (ENDP) Ireland $3.914B 5.62
Taro Pharmaceutical Industries (TARO) Israel $3.735B 14.46
Madrigal Pharmaceuticals (MDGL) United States $2.907B 0.00
USANA Health Sciences (USNA) United States $2.648B 23.33
Aerie Pharmaceuticals (AERI) United States $2.543B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.492B 0.00
Heron Therapeutics (HRTX) United States $2.265B 0.00
TESARO (TSRO) United States $2.248B 0.00
Xencor (XNCR) United States $1.954B 0.00
PTC Therapeutics (PTCT) United States $1.922B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.856B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.591B 0.00
Portola Pharmaceuticals (PTLA) United States $1.544B 0.00
Zogenix (ZGNX) United States $1.488B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.475B 18.04
Spectrum Pharmaceuticals (SPPI) United States $1.461B 0.00
Corcept Therapeutics (CORT) United States $1.454B 22.38
TherapeuticsMD (TXMD) United States $1.285B 0.00
Tricida (TCDA) United States $1.224B 0.00
Esperion Therapeutics (ESPR) United States $1.205B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.158B 0.00
ImmunoGen (IMGN) United States $1.118B 0.00
Endocyte (ECYT) United States $1.072B 0.00
Radius Health (RDUS) United States $0.863B 0.00
Karyopharm Therapeutics (KPTI) United States $0.764B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.753B 0.00
Flexion Therapeutics (FLXN) United States $0.698B 0.00
GlycoMimetics (GLYC) United States $0.582B 0.00
Collegium Pharmaceutical (COLL) United States $0.561B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.549B 0.00
Dova Pharmaceuticals (DOVA) United States $0.548B 0.00
ChemoCentryx (CCXI) United States $0.531B 31.03
Dermira (DERM) United States $0.509B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.501B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.491B 0.00
Akebia Therapeutics (AKBA) United States $0.491B 0.00
ArQule (ARQL) United States $0.465B 0.00
OptiNose (OPTN) United States $0.453B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.445B 30.33
Forty Seven (FTSV) United States $0.433B 0.00
Odonate Therapeutics (ODT) United States $0.433B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.426B 0.00
Siga Technologies (SIGA) United States $0.408B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.396B 0.00
Minerva Neurosciences (NERV) United States $0.384B 0.00
Xeris Pharmaceuticals (XERS) United States $0.377B 0.00
Aquestive Therapeutics (AQST) United States $0.376B 0.00
Zafgen (ZFGN) United States $0.368B 0.00
Mast Therapeutics (SVRA) United States $0.358B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.358B 0.00
Depomed (ASRT) United States $0.356B 0.00
Concert Pharmaceuticals (CNCE) United States $0.349B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.342B 0.00
ElectroCore (ECOR) United States $0.341B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.340B 0.00
KalVista Pharmaceuticals (KALV) United States $0.334B 0.00
Majesco Entertainment (PTE) United States $0.331B 0.00
Translate Bio (TBIO) United States $0.323B 0.00
MEI Pharma (MEIP) United States $0.290B 0.00
CASI Pharmaceuticals (CASI) United States $0.283B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.276B 0.00
Tyme Technologies (TYME) United States $0.263B 0.00
Aldeyra Therapeutics (ALDX) United States $0.260B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.260B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.257B 0.00
Aratana Therapeutics (PETX) United States $0.255B 0.00
Opexa Therapeutics (ACER) United States $0.245B 0.00
IMV INC (IMV) Canada $0.241B 0.00
Neon Therapeutics (NTGN) United States $0.238B 0.00
Ocular Therapeutix (OCUL) United States $0.238B 0.00
Ardelyx (ARDX) United States $0.230B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.226B 0.00
Affimed (AFMD) Germany $0.215B 0.00
Calithera Biosciences (CALA) United States $0.212B 0.00
Melinta Therapeutics (MLNT) United States $0.210B 0.00
Galectin Therapeutics (GALT) United States $0.200B 0.00
Molecular Templates (MTEM) United States $0.192B 0.00
Jounce Therapeutics (JNCE) United States $0.186B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.181B 0.00
Redhill Biopharma (RDHL) Israel $0.177B 0.00
Achaogen (AKAO) United States $0.170B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.168B 0.00
India Globalization Capital (IGC) United States $0.163B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.163B 0.00
ContraFect (CFRX) United States $0.161B 0.00
MediWound (MDWD) Israel $0.160B 0.00
DURECT (DRRX) United States $0.157B 0.00
Lannett Co Inc (LCI) United States $0.156B 1.29
Avadel Pharmaceuticals (AVDL) Ireland $0.155B 0.00
Nature's Sunshine Products (NATR) United States $0.151B 0.00
BioLineRx (BLRX) Israel $0.147B 0.00
Adherex Technologies (FENC) United States $0.146B 0.00
Recro Pharma (REPH) United States $0.145B 0.00
Champions Oncology (CSBR) United States $0.141B 0.00
Infinity Pharmaceuticals (INFI) United States $0.140B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.132B 0.00
ProNAi Therapeutics (SRRA) Canada $0.128B 0.00
Neos Therapeutics (NEOS) United States $0.121B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.121B 0.00
Cardiome Pharma (CORV) Canada $0.115B 0.00
CTI BioPharma (CTIC) United States $0.113B 0.00
ENTASIS THERAPT (ETTX) United States $0.110B 0.00
Rafael Holdings (RFL) United States $0.107B 0.00
Forward Pharma (FWP) Denmark $0.100B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.086B 0.00
Iterum Therapeutics (ITRM) Ireland $0.086B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.084B 0.00
Immune Design (IMDZ) United States $0.082B 0.00
Otonomy (OTIC) United States $0.081B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.075B 0.00
Natural Alternatives (NAII) United States $0.072B 8.11
Nivalis Therapeutics (ALPN) United States $0.070B 0.00
Genocea Biosciences (GNCA) United States $0.065B 0.00
Novan (NOVN) United States $0.060B 0.00
SCYNEXIS (SCYX) United States $0.055B 0.00
Trillium Therapeutics (TRIL) Canada $0.054B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 40.33
Ampio Pharmaceuticals (AMPE) United States $0.047B 0.00
Mannatechorporated (MTEX) United States $0.047B 24.87
Capnia (SLNO) United States $0.042B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.042B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.041B 0.00
KemPharm (KMPH) United States $0.040B 0.00
Heat Biologics (HTBX) United States $0.038B 0.00
Avenue Therapeutics (ATXI) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.94
Onconova Therapeutics (ONTX) United States $0.034B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.033B 0.00
IsoRay (ISR) United States $0.032B 0.00
Biomerica (BMRA) United States $0.030B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.028B 0.00
Lipocine (LPCN) United States $0.028B 0.00
Citius Pharmaceuticals (CTXR) United States $0.027B 0.00
Aviragen Therapeutics (VXRT) United States $0.027B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.026B 9.30
Jaguar Animal Health (JAGX) United States $0.026B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.025B 0.00
Can-Fite Biopharma (CANF) Israel $0.025B 0.00
HANCOCK JAFFE (HJLI) United States $0.025B 0.00
Xenetic Biosciences (XBIO) United States $0.024B 0.00
ESSA Pharma (EPIX) Canada $0.023B 0.00
NanoViricides (NNVC) United States $0.022B 0.00
Aradigm (ARDM) United States $0.020B 0.00
Shineco (TYHT) China $0.019B 2.11
Cyanotech (CYAN) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.017B 0.00
Midatech Pharma (MTP) United Kingdom $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.014B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.012B 0.00
Skyline Medical (AIPT) United States $0.012B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.008B 0.00
Pain Therapeutics (PTIE) United States $0.008B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Apricus Biosciences (APRI) United States $0.007B 0.00
PharmAthene (ALT) United States $0.007B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.006B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Intellipharmaceutics (IPCI) Canada $0.003B 0.00
RXi Pharmaceuticals (RXII) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00